NCT07739212

Brief Summary

This is a retrospective data collection from patients treated with the bipolar radiofrequency applicator (Coaxipolar) of the Accent devices. Patient files were screened for suitable candidates providing before and after treatment pictures for blinded evaluation. The safety and efficacy of bipolar RF technology, both as a standalone treatment and in combination with unipolar RF, for facial contouring and the reduction of wrinkles and fine lines is investigated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 5, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

July 21, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 31, 2026

Completed
Last Updated

July 31, 2026

Status Verified

July 1, 2025

Enrollment Period

2 months

First QC Date

July 21, 2026

Last Update Submit

July 29, 2026

Conditions

Keywords

wrinkles, skin laxity,

Outcome Measures

Primary Outcomes (1)

  • GAIS

    Skin laxity was assessed using the Global Aesthetic Improvement Scale (GAIS; 0-4 scale), GAIS 5-point scale (0 = worse, 1 = no change, 2 = mild improvement, 3 = much improvement, 4 = very much improvement)

    From enrollment to the end of treatment at 24 weeks

Secondary Outcomes (3)

  • Fitzpatrick-wrinkle-scale

    From enrollment to the end of treatment at 24 weeks

  • VISIA Score Change (if applicable)

    From enrollment to the end of treatment at 24 weeks

  • Patient satisfaction (if applicable)

    From enrollment to the end of treatment at 24 weeks

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

A total of up to 150 adult subjects of both genders and all skin types are to be included if they meet all of the inclusion and none of the exclusion criteria. Investigator is collecting data retrospectively from their respective patient pool.

You may qualify if:

  • Healthy male or female ≥18 years old.
  • Complete Medical History records are available
  • Documented baseline and follow-up digital images are available
  • Treatment with one applicator only for the approved indication for bipolar applicator such as skin laxity, wrinkles and rhytids
  • provided consent for before and after (B\&A) pictures for evaluation Fitzpatrick skin type I- VI

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Estethica Clinic

Pristina, 10000, Kosovo

Location

MeSH Terms

Conditions

Cutis Laxa

Condition Hierarchy (Ancestors)

Skin Diseases, GeneticGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesConnective Tissue DiseasesSkin and Connective Tissue DiseasesSkin Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 21, 2026

First Posted

July 31, 2026

Study Start

July 5, 2025

Primary Completion

August 30, 2025

Study Completion

December 30, 2025

Last Updated

July 31, 2026

Record last verified: 2025-07

Locations